Nanoforming has emerged as a patient- and planet-centric approach to enhancing medicines in development. By reducing the size of drug particles, the technique can open up exciting new opportunities – from increasing bioavailability to enabling sustained drug delivery. In this presentation, Nanoform CCO Christian Jones delves into the benefits that can be unlocked for both patients and the planet through the Nanoform toolbox, supported by data from relevant case studies.